Study of the usefulness of neoadjuvant chemo-hormone therapy for high-risk prostate cancer
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000030346
- Lead Sponsor
- Fujita Health University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who receiving hormonal therapy. 2. AST/ALT more than 100 IU/L by screening. 3. Patients who are judged inteligible for entry to this study principal investigator or sub-investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2Y Desease-Free Survival (PSA =>0.2ng/ml)
- Secondary Outcome Measures
Name Time Method Perioperative complications